This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.

Related Keywords

Montreal , Quebec , Canada , Tordera , Comunidad Autonoma De Cataluna , Spain , Boston , Massachusetts , United States , Tafalla , Navarra , Isorna , Galicia , United Kingdom , Japan , Spanish , Comorbid Asthma , Novartis Pharma Gmb , Blanco Aparicio , Novartis Farmac , Trelegy Ellipta , Chiesi Farmaceutici , Shrikant Kulkarni , Enerzair Breezhaler , Evelino Szalai , Warren Alpert Medical School Of Brown University , Department Of Medicine , Japan Medical Data Center , Fishawack Health , Glaxosmithkline , Fishawack Indicia Ltd , Johns Hopkins University School Of Medicine , Research Triangle Park , Global Initiative For Asthma , Division Of Pulmonary , Optum Research Database , Analysis Group Inc , Interasma Global Asthma Association , International Cross , Study Group , Metrics Plus , Global Initiative , Appendix Figure , Appendix Table , Charlson Comorbidity Index , New Users , Appendix Figures , Therapy Treatment Patterns , Index Among , Critical Care Medicine , Johns Hopkins University School , Analysis Group , Warren Alpert Medical School , Brown University , Asthma Management , Allergy Clin Immunol , Curr Med Res , Care Respir , International Cross Sectional , Longitudinal Assessment , Asthma Control , Novartis Pharma Gmbh , Global Asthma Association , Initial Treatment Of Asthma , Asthma Control Testscore , Asthma , Triple Therapy , Inhaler ,